2,2,2-TRICHLORO-N-[2-(INDOL-3-YL)-ETHYL]-N-[4-(TRIMETHYLSILYLOXY)-CYCLOHEX-3-ENYL]-ACETAMIDE
Compound with spectra: 1 NMR
![2,2,2-TRICHLORO-N-[2-(INDOL-3-YL)-ETHYL]-N-[4-(TRIMETHYLSILYLOXY)-CYCLOHEX-3-ENYL]-ACETAMIDE](/api/compound/LioPzMjRHmL.png?ph=true&h=300&w=458 "2,2,2-TRICHLORO-N-[2-(INDOL-3-YL)-ETHYL]-N-[4-(TRIMETHYLSILYLOXY)-CYCLOHEX-3-ENYL]-ACETAMIDE")
| SpectraBase Compound ID | LioPzMjRHmL |
|---|---|
| InChI | InChI=1S/C21H27Cl3N2O2Si/c1-29(2,3)28-17-10-8-16(9-11-17)26(20(27)21(22,23)24)13-12-15-14-25-19-7-5-4-6-18(15)19/h4-7,10,14,16,25H,8-9,11-13H2,1-3H3 |
| InChIKey | WKDYPQRBHVAVGJ-UHFFFAOYSA-N |
| Mol Weight | 473.9 g/mol |
| Molecular Formula | C21H27Cl3N2O2Si |
| Exact Mass | 472.090738 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CHLOROFORM-D1 |
5,6-Dihydro-6-isopropyl-1-[2'-(indol-3"-yl)ethyl]-4-methoxypyridin-2(1H)-one
4-imidazolidinepropanamide, 1-[2-(1H-indol-3-yl)ethyl]-2,5-dioxo-N-(2-propenyl)-, (4S)-
4-imidazolidinepropanamide, N-cyclohexyl-1-[2-(1H-indol-3-yl)ethyl]-2,5-dioxo-, (4S)-
No Name
5-ethyl-4-(2-hydroxyethyl)-1-[2-(1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridine-2-carbonitrile
2(1H)-Quinolinone, 3,4,5,6,7,8-hexahydro-1-[2-(1H-indol-3-yl)ethyl]-
Succinimide, 2-[2-[(benzyloxy)methyl]butyl]-N-(2-indol-3-ylethyl)-
5-(2--ethyl)-2,3,6,7-tetrahydro-furo(3,2-C)pyridin-4(5H)-one
3-(1-hydroxyethyl)-1-[2-(1H-indol-3-yl)ethyl]-3,4-dihydro-2H-pyridine-5-carboxylic acid methyl ester
1-[2-(3-Indolyl)ethyl]-2-methyl-1,5,6,7-tetrahydroimidazo[1,2,a]pyrimidine
| Title | Journal or Book | Year |
|---|---|---|
| Radical promoted cyclisations of trichloroacetamides with silyl enol ethers and enol acetates: the role of the hydride reagent [tris(trimethylsilyl)silane vs. tributylstannane] | Journal of the Chemical Society, Perkin Transactions 1 | 1999 |